DarioHealth stock holds near USD 71 million market value

DarioHealth Corp. (DRIO) stock closed at USD 7.24 on September 4, 2026, giving the company a market capitalization of USD 70.948 million after a 3.72 percent gain on the day and a 2.21 percent after-hours move to USD 7.40.

Board change, share reaction

TipRanks reported on September 4, 2026 that DarioHealth said board member Lawrence Leisure retired on September 2, 2026, effective the same day. The stock also traded between USD 6.79 and USD 7.30 on September 4, 2026, with volume of 20,641 shares.

The move left DRIO 36.38 percent lower year to date, even though the share price was still well above the 52-week low of USD 5.84 and below the 52-week high of USD 17.74.

Q1 FY26 still frames the story

Yahoo Finance shows Q1 FY26 revenue of USD 5.58 million and earnings of USD -8.25 million, with a profit margin of -147.73 percent. It also lists trailing revenue of USD 21 million and diluted EPS of USD -14.87.

That comparison matters more than the short-term board news for investors: Q1 FY26 revenue of USD 5.58 million versus trailing revenue of USD 21 million points to a company still working through a weak earnings base.

Dario platform stays central

The companys platform spans Dario Connect, Dario Mind, Dario Move and Dario Health, with offerings aimed at diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. Yahoo Finance describes DarioHealth as a health information services company with 160 employees and a fiscal year end on December 31.

Stock near its range

DRIO changed hands at USD 7.24 on September 4, 2026, after hours at USD 7.40, and the 52-week range ran from USD 5.84 to USD 17.74. DarioHealth stock remains a small-cap healthcare name trading inside that band, with market value the clearest same-day reference point.